Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease.
Market Analysis and Insights: Global Parkinsons disease Drug Market
The global Parkinsons disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Parkinsons disease Drug Scope and Segment
The global Parkinsons disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
By the end users/application, this report covers the following segments
Hospital
Online
Retail Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Parkinsons disease Drug market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Parkinsons disease Drug key manufacturers in this market include:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market Analysis and Insights: Global Parkinsons disease Drug Market
The global Parkinsons disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Parkinsons disease Drug Scope and Segment
The global Parkinsons disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
By the end users/application, this report covers the following segments
Hospital
Online
Retail Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Parkinsons disease Drug market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Parkinsons disease Drug key manufacturers in this market include:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
1 Parkinsons disease Drug Market Overview
1.1 Parkinsons disease Drug Product Overview
1.2 Parkinsons disease Drug Market Segment by Type
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Global Parkinsons disease Drug Market Size by Type
1.3.1 Global Parkinsons disease Drug Market Size Overview by Type (2016-2027)
1.3.2 Global Parkinsons disease Drug Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Parkinsons disease Drug Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Parkinsons disease Drug Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Parkinsons disease Drug Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Parkinsons disease Drug Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Parkinsons disease Drug Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.2 Europe Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
2 Global Parkinsons disease Drug Market Competition by Company
2.1 Global Top Players by Parkinsons disease Drug Sales (2016-2021)
2.2 Global Top Players by Parkinsons disease Drug Revenue (2016-2021)
2.3 Global Top Players Parkinsons disease Drug Price (2016-2021)
2.4 Global Top Manufacturers Parkinsons disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parkinsons disease Drug Market Competitive Situation and Trends
2.5.1 Parkinsons disease Drug Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Parkinsons disease Drug Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons disease Drug as of 2020)
2.7 Date of Key Manufacturers Enter into Parkinsons disease Drug Market
2.8 Key Manufacturers Parkinsons disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parkinsons disease Drug Status and Outlook by Region
3.1 Global Parkinsons disease Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Parkinsons disease Drug Historic Market Size by Region
3.2.1 Global Parkinsons disease Drug Sales in Volume by Region (2016-2021)
3.2.2 Global Parkinsons disease Drug Sales in Value by Region (2016-2021)
3.2.3 Global Parkinsons disease Drug Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Parkinsons disease Drug Forecasted Market Size by Region
3.3.1 Global Parkinsons disease Drug Sales in Volume by Region (2022-2027)
3.3.2 Global Parkinsons disease Drug Sales in Value by Region (2022-2027)
3.3.3 Global Parkinsons disease Drug Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Parkinsons disease Drug by Application
4.1 Parkinsons disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Online
4.1.3 Retail Pharmacies
4.2 Global Parkinsons disease Drug Market Size by Application
4.2.1 Global Parkinsons disease Drug Market Size Overview by Application (2016-2027)
4.2.2 Global Parkinsons disease Drug Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Parkinsons disease Drug Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Parkinsons disease Drug Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Parkinsons disease Drug Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Parkinsons disease Drug Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Parkinsons disease Drug Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.2 Europe Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
5 North America Parkinsons disease Drug by Country
5.1 North America Parkinsons disease Drug Historic Market Size by Country
5.1.1 North America Parkinsons disease Drug Sales in Volume by Country (2016-2021)
5.1.2 North America Parkinsons disease Drug Sales in Value by Country (2016-2021)
5.2 North America Parkinsons disease Drug Forecasted Market Size by Country
5.2.1 North America Parkinsons disease Drug Sales in Volume by Country (2022-2027)
5.2.2 North America Parkinsons disease Drug Sales in Value by Country (2022-2027)
6 Europe Parkinsons disease Drug by Country
6.1 Europe Parkinsons disease Drug Historic Market Size by Country
6.1.1 Europe Parkinsons disease Drug Sales in Volume by Country (2016-2021)
6.1.2 Europe Parkinsons disease Drug Sales in Value by Country (2016-2021)
6.2 Europe Parkinsons disease Drug Forecasted Market Size by Country
6.2.1 Europe Parkinsons disease Drug Sales in Volume by Country (2022-2027)
6.2.2 Europe Parkinsons disease Drug Sales in Value by Country (2022-2027)
7 Asia-Pacific Parkinsons disease Drug by Region
7.1 Asia-Pacific Parkinsons disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Parkinsons disease Drug Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Parkinsons disease Drug Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Parkinsons disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Parkinsons disease Drug Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Parkinsons disease Drug Sales in Value by Region (2022-2027)
8 Latin America Parkinsons disease Drug by Country
8.1 Latin America Parkinsons disease Drug Historic Market Size by Country
8.1.1 Latin America Parkinsons disease Drug Sales in Volume by Country (2016-2021)
8.1.2 Latin America Parkinsons disease Drug Sales in Value by Country (2016-2021)
8.2 Latin America Parkinsons disease Drug Forecasted Market Size by Country
8.2.1 Latin America Parkinsons disease Drug Sales in Volume by Country (2022-2027)
8.2.2 Latin America Parkinsons disease Drug Sales in Value by Country (2022-2027)
9 Middle East and Africa Parkinsons disease Drug by Country
9.1 Middle East and Africa Parkinsons disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Parkinsons disease Drug Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Parkinsons disease Drug Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Parkinsons disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Parkinsons disease Drug Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Parkinsons disease Drug Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Parkinsons disease Drug Business
10.1 Teva
10.1.1 Teva Corporation Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Parkinsons disease Drug Products Offered
10.1.5 Teva Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Corporation Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Parkinsons disease Drug Products Offered
10.2.5 Novartis AG Recent Development
10.3 GSK
10.3.1 GSK Corporation Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.3.4 GSK Parkinsons disease Drug Products Offered
10.3.5 GSK Recent Development
10.4 AbbVie
10.4.1 AbbVie Corporation Information
10.4.2 AbbVie Introduction and Business Overview
10.4.3 AbbVie Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.4.4 AbbVie Parkinsons disease Drug Products Offered
10.4.5 AbbVie Recent Development
10.5 Merck
10.5.1 Merck Corporation Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Merck Parkinsons disease Drug Products Offered
10.5.5 Merck Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Corporation Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Impax Laboratories
10.7.1 Impax Laboratories Corporation Information
10.7.2 Impax Laboratories Introduction and Business Overview
10.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
10.7.5 Impax Laboratories Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Corporation Information
10.8.2 Lundbeck Introduction and Business Overview
10.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Lundbeck Parkinsons disease Drug Products Offered
10.8.5 Lundbeck Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Corporation Information
10.9.2 Sun Pharma Introduction and Business Overview
10.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Sun Pharma Parkinsons disease Drug Products Offered
10.9.5 Sun Pharma Recent Development
10.10 Wockhardt
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Parkinsons disease Drug Product Category, Application and Specification
10.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Wockhardt Recent Development
10.11 UCB
10.11.1 UCB Corporation Information
10.11.2 UCB Introduction and Business Overview
10.11.3 UCB Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.11.4 UCB Parkinsons disease Drug Products Offered
10.11.5 UCB Recent Development
10.12 Bausch Health
10.12.1 Bausch Health Corporation Information
10.12.2 Bausch Health Introduction and Business Overview
10.12.3 Bausch Health Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Bausch Health Parkinsons disease Drug Products Offered
10.12.5 Bausch Health Recent Development
10.13 Acadia
10.13.1 Acadia Corporation Information
10.13.2 Acadia Introduction and Business Overview
10.13.3 Acadia Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Acadia Parkinsons disease Drug Products Offered
10.13.5 Acadia Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parkinsons disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parkinsons disease Drug Industrial Chain Analysis
11.4 Parkinsons disease Drug Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parkinsons disease Drug Distributors
12.3 Parkinsons disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Parkinsons disease Drug Product Overview
1.2 Parkinsons disease Drug Market Segment by Type
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Global Parkinsons disease Drug Market Size by Type
1.3.1 Global Parkinsons disease Drug Market Size Overview by Type (2016-2027)
1.3.2 Global Parkinsons disease Drug Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Parkinsons disease Drug Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Parkinsons disease Drug Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Parkinsons disease Drug Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Parkinsons disease Drug Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Parkinsons disease Drug Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.2 Europe Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Parkinsons disease Drug Sales Breakdown by Type (2016-2021)
2 Global Parkinsons disease Drug Market Competition by Company
2.1 Global Top Players by Parkinsons disease Drug Sales (2016-2021)
2.2 Global Top Players by Parkinsons disease Drug Revenue (2016-2021)
2.3 Global Top Players Parkinsons disease Drug Price (2016-2021)
2.4 Global Top Manufacturers Parkinsons disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parkinsons disease Drug Market Competitive Situation and Trends
2.5.1 Parkinsons disease Drug Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Parkinsons disease Drug Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons disease Drug as of 2020)
2.7 Date of Key Manufacturers Enter into Parkinsons disease Drug Market
2.8 Key Manufacturers Parkinsons disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parkinsons disease Drug Status and Outlook by Region
3.1 Global Parkinsons disease Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Parkinsons disease Drug Historic Market Size by Region
3.2.1 Global Parkinsons disease Drug Sales in Volume by Region (2016-2021)
3.2.2 Global Parkinsons disease Drug Sales in Value by Region (2016-2021)
3.2.3 Global Parkinsons disease Drug Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Parkinsons disease Drug Forecasted Market Size by Region
3.3.1 Global Parkinsons disease Drug Sales in Volume by Region (2022-2027)
3.3.2 Global Parkinsons disease Drug Sales in Value by Region (2022-2027)
3.3.3 Global Parkinsons disease Drug Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Parkinsons disease Drug by Application
4.1 Parkinsons disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Online
4.1.3 Retail Pharmacies
4.2 Global Parkinsons disease Drug Market Size by Application
4.2.1 Global Parkinsons disease Drug Market Size Overview by Application (2016-2027)
4.2.2 Global Parkinsons disease Drug Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Parkinsons disease Drug Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Parkinsons disease Drug Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Parkinsons disease Drug Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Parkinsons disease Drug Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Parkinsons disease Drug Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Parkinsons disease Drug Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.2 Europe Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Parkinsons disease Drug Sales Breakdown by Application (2016-2021)
5 North America Parkinsons disease Drug by Country
5.1 North America Parkinsons disease Drug Historic Market Size by Country
5.1.1 North America Parkinsons disease Drug Sales in Volume by Country (2016-2021)
5.1.2 North America Parkinsons disease Drug Sales in Value by Country (2016-2021)
5.2 North America Parkinsons disease Drug Forecasted Market Size by Country
5.2.1 North America Parkinsons disease Drug Sales in Volume by Country (2022-2027)
5.2.2 North America Parkinsons disease Drug Sales in Value by Country (2022-2027)
6 Europe Parkinsons disease Drug by Country
6.1 Europe Parkinsons disease Drug Historic Market Size by Country
6.1.1 Europe Parkinsons disease Drug Sales in Volume by Country (2016-2021)
6.1.2 Europe Parkinsons disease Drug Sales in Value by Country (2016-2021)
6.2 Europe Parkinsons disease Drug Forecasted Market Size by Country
6.2.1 Europe Parkinsons disease Drug Sales in Volume by Country (2022-2027)
6.2.2 Europe Parkinsons disease Drug Sales in Value by Country (2022-2027)
7 Asia-Pacific Parkinsons disease Drug by Region
7.1 Asia-Pacific Parkinsons disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Parkinsons disease Drug Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Parkinsons disease Drug Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Parkinsons disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Parkinsons disease Drug Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Parkinsons disease Drug Sales in Value by Region (2022-2027)
8 Latin America Parkinsons disease Drug by Country
8.1 Latin America Parkinsons disease Drug Historic Market Size by Country
8.1.1 Latin America Parkinsons disease Drug Sales in Volume by Country (2016-2021)
8.1.2 Latin America Parkinsons disease Drug Sales in Value by Country (2016-2021)
8.2 Latin America Parkinsons disease Drug Forecasted Market Size by Country
8.2.1 Latin America Parkinsons disease Drug Sales in Volume by Country (2022-2027)
8.2.2 Latin America Parkinsons disease Drug Sales in Value by Country (2022-2027)
9 Middle East and Africa Parkinsons disease Drug by Country
9.1 Middle East and Africa Parkinsons disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Parkinsons disease Drug Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Parkinsons disease Drug Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Parkinsons disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Parkinsons disease Drug Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Parkinsons disease Drug Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Parkinsons disease Drug Business
10.1 Teva
10.1.1 Teva Corporation Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Parkinsons disease Drug Products Offered
10.1.5 Teva Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Corporation Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Parkinsons disease Drug Products Offered
10.2.5 Novartis AG Recent Development
10.3 GSK
10.3.1 GSK Corporation Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.3.4 GSK Parkinsons disease Drug Products Offered
10.3.5 GSK Recent Development
10.4 AbbVie
10.4.1 AbbVie Corporation Information
10.4.2 AbbVie Introduction and Business Overview
10.4.3 AbbVie Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.4.4 AbbVie Parkinsons disease Drug Products Offered
10.4.5 AbbVie Recent Development
10.5 Merck
10.5.1 Merck Corporation Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Merck Parkinsons disease Drug Products Offered
10.5.5 Merck Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Corporation Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Impax Laboratories
10.7.1 Impax Laboratories Corporation Information
10.7.2 Impax Laboratories Introduction and Business Overview
10.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
10.7.5 Impax Laboratories Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Corporation Information
10.8.2 Lundbeck Introduction and Business Overview
10.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Lundbeck Parkinsons disease Drug Products Offered
10.8.5 Lundbeck Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Corporation Information
10.9.2 Sun Pharma Introduction and Business Overview
10.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Sun Pharma Parkinsons disease Drug Products Offered
10.9.5 Sun Pharma Recent Development
10.10 Wockhardt
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Parkinsons disease Drug Product Category, Application and Specification
10.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Wockhardt Recent Development
10.11 UCB
10.11.1 UCB Corporation Information
10.11.2 UCB Introduction and Business Overview
10.11.3 UCB Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.11.4 UCB Parkinsons disease Drug Products Offered
10.11.5 UCB Recent Development
10.12 Bausch Health
10.12.1 Bausch Health Corporation Information
10.12.2 Bausch Health Introduction and Business Overview
10.12.3 Bausch Health Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Bausch Health Parkinsons disease Drug Products Offered
10.12.5 Bausch Health Recent Development
10.13 Acadia
10.13.1 Acadia Corporation Information
10.13.2 Acadia Introduction and Business Overview
10.13.3 Acadia Parkinsons disease Drug Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Acadia Parkinsons disease Drug Products Offered
10.13.5 Acadia Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parkinsons disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parkinsons disease Drug Industrial Chain Analysis
11.4 Parkinsons disease Drug Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parkinsons disease Drug Distributors
12.3 Parkinsons disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
